IGC Pharma Inc (IGC)
0.458
+0.03
(+6.51%)
USD |
NYAM |
Apr 26, 16:00
0.48
+0.02
(+4.80%)
After-Hours: 20:00
IGC Pharma 1 Year Total Returns (Daily): 35.50% for April 26, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 26, 2024 | 35.50% |
April 25, 2024 | 29.60% |
April 24, 2024 | 31.01% |
April 23, 2024 | 26.83% |
April 22, 2024 | 23.64% |
April 19, 2024 | 38.42% |
April 18, 2024 | 40.03% |
April 17, 2024 | 76.34% |
April 16, 2024 | 51.40% |
April 15, 2024 | 36.82% |
April 12, 2024 | 33.36% |
April 11, 2024 | 55.93% |
April 10, 2024 | 56.22% |
April 09, 2024 | 69.12% |
April 08, 2024 | 82.35% |
April 05, 2024 | 95.34% |
April 04, 2024 | 105.8% |
April 03, 2024 | 84.34% |
April 02, 2024 | 57.73% |
April 01, 2024 | 40.21% |
March 28, 2024 | 17.65% |
March 27, 2024 | 16.18% |
March 26, 2024 | 17.70% |
March 25, 2024 | 17.99% |
March 22, 2024 | 12.00% |
Date | Value |
---|---|
March 21, 2024 | 3.03% |
March 20, 2024 | 3.77% |
March 19, 2024 | 11.20% |
March 18, 2024 | -0.32% |
March 15, 2024 | -4.81% |
March 14, 2024 | -3.89% |
March 13, 2024 | -6.98% |
March 12, 2024 | -12.11% |
March 11, 2024 | -10.11% |
March 08, 2024 | -12.45% |
March 07, 2024 | -14.17% |
March 06, 2024 | -15.67% |
March 05, 2024 | -12.86% |
March 04, 2024 | -9.30% |
March 01, 2024 | -8.14% |
February 29, 2024 | -9.32% |
February 28, 2024 | -8.16% |
February 27, 2024 | -9.69% |
February 26, 2024 | -8.16% |
February 23, 2024 | -21.50% |
February 22, 2024 | -30.77% |
February 21, 2024 | -26.47% |
February 20, 2024 | -24.36% |
February 16, 2024 | -21.61% |
February 15, 2024 | -24.17% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.92%
Minimum
Oct 02 2019
536.6%
Maximum
Mar 19 2021
15.30%
Average
-27.87%
Median
Oct 23 2023
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -34.25% |
AIM ImmunoTech Inc | -13.42% |
NovaBay Pharmaceuticals Inc | -94.23% |
Protalix BioTherapeutics Inc | -57.41% |
Palatin Technologies Inc | -22.88% |